Wed, Jul 23, 2014, 2:15 PM EDT - U.S. Markets close in 1 hr 45 mins


% | $
Click the to save as a favorite.

Inovio Pharmaceuticals, Inc. Message Board

  • inouknow inouknow Mar 24, 2014 4:07 AM Flag

    News from VGX Site

    Via google translate, but at least you can understand enough of the announcement:

    X Inter (KOSPI: 011000) "Over the past 22 days, Keimyung University School of Medicine opened in 2014 between the Association for Single Topic Symposium Proceedings of the company through the research and development of DNA vaccines in the treatment of chronic hepatitis C (VGX-6150) for clinical research content was introduced, "he said.

    Recent advances in the treatment of viral hepatitis, the theme of the symposium conducted geumbeon heojeong professor at Pusan ​​National University College of Medicine, Section of new chronic hepatitis C treatment, a therapeutic vaccine (VGX-6150) entitled "Current progress in using electric drilling machines VGX-6150 DNA vaccine therapy clinical trial for safety evaluation for Phase 1 multicenter, open, progress in the form of increased capacity, the new treatment of chronic hepatitis C is the expectation, "he said.

    Professor heojeong announcement, "VGX International clinical trials being developed in the treatment of chronic hepatitis C DNA vaccine (VGX-6150) is the most difficult to treat existing standard treatments first genotypes (1a, 1b) of the amino acid sequence of the virus database analyzing the antigen within the amino acid common sequence to find and enhanced the maximum concordance between the virus, antigens for inducing immune responses to a wide range of amino acid sequences were selected as "high balhimyeo" Thus produced DNA vaccine (VGX-6150) is 1000 times the incidence antigen, the immune response induced by 100-fold increase in the electroporation method has the characteristics of high efficiency, the body passed to the already confirmed non-clinical safety and efficacy in a bar, "he said.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
12.91+1.77(+15.89%)2:14 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.